Highly sensitive fast determination of entecavir in rat urine by means of hydrophilic interaction chromatography-ultra-high-performance liquid chromatography-tandem mass spectrometry

Journal of Chromatography A

Volumn 1259, Issue , 2012, Pages 237-243

  Nováková, Lucie ^a   Gottvald, Tomáš ^a   Vlčková, Hana ^a   Trejtnar, František ^a   Mandíková, Jana ^a   Solich, Petr ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Entecavir; Hydrophilic interaction chromatography (HILIC); MS MS; Rat urine; Solid phase extraction; UHPLC

Indexed keywords

ENTECAVIR; HYDROPHILIC INTERACTION CHROMATOGRAPHY; MS/MS; RAT URINE; SOLID-PHASE EXTRACTION; UHPLC;

ACETONITRILE; AMIDES; AMMONIUM COMPOUNDS; BODY FLUIDS; FORMIC ACID; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; RATS; VIRUSES;

CHROMATOGRAPHY;

ACETONITRILE; AMMONIUM ACETATE; CARBON 13; ENTECAVIR; FORMIC ACID; NITROGEN 15;

ACCURACY; ANALYTICAL ERROR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SELECTIVITY; DRUG SENSITIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELUTION; FLOW RATE; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LIMIT OF QUANTITATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GUANINE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIMIT OF DETECTION; LINEAR MODELS; RATS; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

HEPATITIS B VIRUS; RATTUS;

EID: 84866313490     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2012.03.078     Document Type: Article

References (17)

1. Yan J.-H., Bifano M., Olsen S., Smith R.A., Zhang D., Grasela D.M., LaCreta F. J. Clin. Pharmacol. 2006, 46:1250.
2. Innaimo S.F., Seifer M., Bisacchi G.S., Standring D.N., Zaher R., Colonno R.J. Antimicrob. Agents Chemother. 1997, 41:1444.
3. Colonno R.J., Genovesi E.V., Medina I., Lamb L., Durham S.K., Huang M.L., Corey L., Littlejohn M., Locarnini S., Tennat B.C., Rose B., Clark J.M. J. Infect. Dis. 2011, 184:1236.
4. Challa B.R., Awen B.Z., Chandu B.R., Rihanaparveen S. J. Chromatogr. B 2011, 879:769.
5. Zhang D., Fu Y., Gale J.P., Furby A.F., Arnold M.E. J. Pharm. Biomed. Anal. 2009, 49:1027.
6. Zhao F.-J., Tang H., Zhang Q.-H., Yang J., Davey A.K., Wang J.-p. J. Chromatogr. B 2012, 881-882:119.
7. Fountain K.J., Xu J., Diehl D.M., Morisson D. J. Sep. Sci. 2010, 33:740.
8. Goucher E., Kicman A., Wolff K., Smith N., Jickells S. J. Sep. Sci. 2010, 33:955.
9. Committee for Medicinal Products for Human Use Guideline on Validation of Bioanalytical Methods 2010, EMEA, London, UK.
10. Gosetti F., Mazzucco E., Zampieri D., Gennaro M.C. J. Chromatogr. A 2010, 1217:3929.
11. Trufelli H., Palma P., Famiglini G., Cappiello A. Mass Spectrom. Rev. 2011, 30:491.
12. Jemal M., Schuster A., Whigan D.B. Rapid. Commun. Mass Spectrom. 2003, 17:1723.
13. Stokvis E., Rosing H., Beijnen J.H. Rapid Commun. Mass Spectrom. 2005, 19:401.
14. Wang S., Cyronak M., Yang E. J. Pharm. Biomed. Anal. 2007, 43:701.
15. Lindegardh N., Annerberg A., White N.J., Day N.P.J. J. Chromatogr. B 2008, 862:227.
16. International Conference on Harmonization (ICH). Q2 (R1): Text on Validation of Analytical Procedures, US FDA Federal Register (2005).
17. Ruta J., Rudaz S., McCalley D.V., Veuthey J.-L., Guillarme D. J. Chromatogr. A 2010, 1217:8230.